Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition (Q40884725)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

phosphorylation

0 references

author name string

A M Domina

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

J H Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

R W Craig

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

275

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

21688-21694

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Bcl-2 phosphorylation required for anti-apoptosis function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Inactivation of Bcl-2 by phosphorylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Human and mouse chromosomal mapping of the myeloid cell leukemia-1 gene: MCL1 maps to human chromosome 1q21, a region that is frequently altered in preneoplastic and neoplastic disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

A synthetic inhibitor of the mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Growth factors and mitogen-activated protein kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

The cloning and expression of human deoxyribonuclease II. A possible role in apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

The bcl-2 gene family

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000915200

21 January 2018

Identifiers

10.1074/JBC.M000915200

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40884725&oldid=1909567967"